NEW YORK ( TheStreet) -- Investors have an vibrant earnings week starting Monday when over 400 companies report their latest quarterly results. You probably won't follow them all, and neither will I.
I selected the top most potentially market moving companies to concentrate on. My previous earnings preview focus was "Microsoft Is a Buy Before Earnings Release." Inside this preview, I will include specific companies that I may trade myself.
Currently 13 out of 21 analysts rate the company a hold, while seven recommend buying and one recommends selling. Analysts may have missed a good one. In the last 12 months, the shares have substantially appreciated. The one year return is 22 percent, and the average analyst target price for Bristol-Myers Squibb is below the current market price at $37.28. The highest target is $45 with a low target of only $26. The technical analysis appears strong. A rising 60-day moving average is above a rising 200 day moving average. Bristol-Myers is in a typical bull trend. Trend followers watch for this pattern and will hold a position until a technical break results in a signal to leave. Bristol-Myers distributes $1.40 a year in dividends for an appealing yield of 3.4%. The combination of a large yield with strong fundamentals is why I featured it in the previously mentioned article. I believe they will beat the earnings estimate, but regardless, Bristol-Myers has the makings for a strong long-term hold. At the time of writing and from the current short interest report, the short interest is slight and not a source of distraction. The small amount of short interest is 2.1%. BMY Revenue Quarterly data by YCharts